Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Fly Intel: Wall Street's top stories for Tuesday » 16:43
04/20/21
04/20
16:43
04/20/21
16:43
IBM

IBM

$138.16 /

+5.07 (+3.81%)

, JNJ

Johnson & Johnson

$166.47 /

+3.66 (+2.25%)

, TRV

Travelers

$155.73 /

+1.28 (+0.83%)

, PG

Procter & Gamble

$137.76 /

+1.31 (+0.96%)

, UAL

United Airlines

$50.29 /

-4.72 (-8.58%)

, KSU

Kansas City Southern

$295.55 /

+39.22 (+15.30%)

, CNI

Canadian National

$110.17 /

-7.92 (-6.71%)

, CP

Canadian Pacific

$354.85 /

-10.33 (-2.83%)

, AAPL

Apple

$133.12 /

-1.74 (-1.29%)

, MSFT

Microsoft

$258.22 /

-0.68 (-0.26%)

, NNDM

Nano Dimension

$7.14 /

+0.505 (+7.61%)

, SNDX

Syndax

$13.42 /

-5.955 (-30.74%)

, FUTU

Futu Holdings

$136.22 /

-41.76 (-23.46%)

, CRSP

Crispr Therapeutics

$121.66 /

+6.5302 (+5.67%)

, VRTX

Vertex Pharmaceuticals

$219.96 /

+1.07 (+0.49%)

The major averages moved…

ShowHide Related Items >><<
IBM IBM
$138.16 /

+5.07 (+3.81%)

JNJ Johnson & Johnson
$166.47 /

+3.66 (+2.25%)

TRV Travelers
$155.73 /

+1.28 (+0.83%)

PG Procter & Gamble
$137.76 /

+1.31 (+0.96%)

UAL United Airlines
$50.29 /

-4.72 (-8.58%)

KSU Kansas City Southern
$295.55 /

+39.22 (+15.30%)

CNI Canadian National
$110.17 /

-7.92 (-6.71%)

CP Canadian Pacific
$354.85 /

-10.33 (-2.83%)

AAPL Apple
$133.12 /

-1.74 (-1.29%)

MSFT Microsoft
$258.22 /

-0.68 (-0.26%)

NNDM Nano Dimension
$7.14 /

+0.505 (+7.61%)

SNDX Syndax
$13.42 /

-5.955 (-30.74%)

FUTU Futu Holdings
$136.22 /

-41.76 (-23.46%)

CRSP Crispr Therapeutics
$121.66 /

+6.5302 (+5.67%)

VRTX Vertex Pharmaceuticals
$219.96 /

+1.07 (+0.49%)

IBM IBM
$138.16 /

+5.07 (+3.81%)

07:32 Today Credit Suisse
IBM price target raised to $165 from $160 at Credit Suisse
07:09 Today Stifel
IBM price target raised to $151 from $147 at Stifel
06:50 Today Morgan Stanley
IBM price target raised to $152 at Morgan Stanley after Q1 results show progress
06:48 Today BMO Capital
IBM price target raised to $150 from $138 at BMO Capital
JNJ Johnson & Johnson
$166.47 /

+3.66 (+2.25%)

04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
TRV Travelers
$155.73 /

+1.28 (+0.83%)

04/01/21 Credit Suisse
Travelers price target raised to $153 from $142 at Credit Suisse
03/31/21 Citi
Travelers price target raised to $155 from $142 at Citi
03/24/21 Barclays
Travelers price target raised to $165 from $155 at Barclays
03/12/21 MKM Partners
Travelers price target raised to $185 from $175 at MKM Partners
PG Procter & Gamble
$137.76 /

+1.31 (+0.96%)

04/16/21 JPMorgan
Procter & Gamble price target lowered to $148 from $153 at JPMorgan
03/02/21 BofA
Procter & Gamble removed from the US 1 List at BofA
01/28/21 Stifel
Stifel downgrades Procter & Gamble to Hold on emerging headwinds
01/28/21 Stifel
Procter & Gamble downgraded to Hold from Buy at Stifel
UAL United Airlines
$50.29 /

-4.72 (-8.58%)

04/16/21
Fly Intel: Top five analyst upgrades
04/16/21 Argus
United Airlines upgraded to Buy on capacity and cost plans at Argus
04/16/21 Argus
United Airlines upgraded to Buy from Hold at Argus
04/15/21 Barclays
United Airlines price target raised to $62 from $44 at Barclays
KSU Kansas City Southern
$295.55 /

+39.22 (+15.30%)

04/19/21 Raymond James
Kansas City Southern downgraded to Outperform from Strong Buy at Raymond James
04/19/21 Raymond James
Kansas City Southern downgraded to Outperform from Strong Buy at Raymond James
04/15/21
Fly Intel: Top five analyst downgrades
04/15/21 Wells Fargo
Kansas City Southern downgraded to Equal Weight from Overweight at Wells Fargo
CNI Canadian National
$110.17 /

-7.92 (-6.71%)

04/09/21 Scotiabank
Canadian National price target raised to C$145 from C$140 at Scotiabank
03/31/21 National Bank
Canadian National price target raised to C$147 from C$137 at National Bank
03/26/21 CIBC
Canadian National price target raised to C$148 from C$142 at CIBC
03/26/21 Vertical Research
Canadian National reinstated with a Hold at Vertical Research
CP Canadian Pacific
$354.85 /

-10.33 (-2.83%)

04/15/21
Fly Intel: Top five analyst upgrades
04/15/21 Barclays
Canadian Pacific upgraded to Overweight from Equal Weight at Barclays
04/09/21 Scotiabank
Canadian Pacific price target raised to C$516 from C$510 at Scotiabank
04/06/21 Susquehanna
Canadian Pacific-KSU deal should clear regulatory hurdles, says Susquehanna
AAPL Apple
$133.12 /

-1.74 (-1.29%)

16:01 Today Wells Fargo
Apple events points to faster than expected 'M1 proliferation' says Wells Fargo
14:46 Today Wedbush
New iPads should give Apple another product tailwind, says Wedbush
04/19/21 Needham
Kulicke & Soffa initiated with a Buy at Needham
04/19/21 Wedbush
Wedbush expecting new Apple iPad launches 'with a few surprises' this week
MSFT Microsoft
$258.22 /

-0.68 (-0.26%)

04/19/21 Morgan Stanley
Morgan Stanley reiterates Microsoft as a Top Pick ahead of earnings
04/13/21 Morgan Stanley
Morgan Stanley says Microsoft 'uniquely positioned' for synergies with Nuance
04/13/21 Craig-Hallum
Nuance downgraded to Hold from Buy at Craig-Hallum
04/13/21 Wedbush
Nuance downgraded to Neutral at Wedbush on Microsoft deal
NNDM Nano Dimension
$7.14 /

+0.505 (+7.61%)

SNDX Syndax
$13.42 /

-5.955 (-30.74%)

02/24/21 Piper Sandler
Kura Oncology price target lowered to $30 from $34 at Piper Sandler
02/18/21 B. Riley Securities
Syndax initiated with Buy, $30 price target at B. Riley
02/17/21 B. Riley Securities
Syndax initiated with a Buy at B. Riley Securities
01/29/21 Baird
Syndax assumed at Outperform at Baird
FUTU Futu Holdings
$136.22 /

-41.76 (-23.46%)

03/17/21 Citi
Futu Holdings price target lowered to $230.30 from $246.50 at Citi
02/26/21 Citi
Futu Holdings price target raised to $246.50 from $119.70 at Citi
02/22/21 86 Research
Futu Holdings downgraded to Hold from Buy at 86 Research
02/16/21 Morgan Stanley
Futu Holdings initiated with an Overweight at Morgan Stanley
CRSP Crispr Therapeutics
$121.66 /

+6.5302 (+5.67%)

12:11 Today Chardan
Amended pact may show Vertex confidence in Crisper program, says Chardan
03/17/21 Guggenheim
Editas Medicine assumed with a Neutral at Guggenheim
03/04/21 JMP Securities
Crispr Therapeutics initiated with an Outperform at JMP Securities
03/01/21 Barclays
Crispr Therapeutics price target raised to $140 from $113 at Barclays
VRTX Vertex Pharmaceuticals
$219.96 /

+1.07 (+0.49%)

12:11 Today Chardan
Amended pact may show Vertex confidence in Crisper program, says Chardan
03/25/21 Citi
Citi likes share setup for Vertex Pharmaceuticals, adds to Focus List
02/23/21 Baird
Baird upgrades Vertex Pharmaceuticals, shares attractive ahead of readouts
02/23/21 Baird
Vertex Pharmaceuticals upgraded to Outperform from Neutral at Baird
IBM IBM
$138.16 /

+5.07 (+3.81%)

JNJ Johnson & Johnson
$166.47 /

+3.66 (+2.25%)

TRV Travelers
$155.73 /

+1.28 (+0.83%)

PG Procter & Gamble
$137.76 /

+1.31 (+0.96%)

UAL United Airlines
$50.29 /

-4.72 (-8.58%)

KSU Kansas City Southern
$295.55 /

+39.22 (+15.30%)

CNI Canadian National
$110.17 /

-7.92 (-6.71%)

CP Canadian Pacific
$354.85 /

-10.33 (-2.83%)

AAPL Apple
$133.12 /

-1.74 (-1.29%)

MSFT Microsoft
$258.22 /

-0.68 (-0.26%)

NNDM Nano Dimension
$7.14 /

+0.505 (+7.61%)

SNDX Syndax
$13.42 /

-5.955 (-30.74%)

CRSP Crispr Therapeutics
$121.66 /

+6.5302 (+5.67%)

VRTX Vertex Pharmaceuticals
$219.96 /

+1.07 (+0.49%)

  • 21
    Apr
  • 09
    Dec
  • 19
    Aug
  • 01
    Jul
  • 30
    Apr
  • 22
    Apr
IBM IBM
$138.16 /

+5.07 (+3.81%)

JNJ Johnson & Johnson
$166.47 /

+3.66 (+2.25%)

TRV Travelers
$155.73 /

+1.28 (+0.83%)

PG Procter & Gamble
$137.76 /

+1.31 (+0.96%)

UAL United Airlines
$50.29 /

-4.72 (-8.58%)

KSU Kansas City Southern
$295.55 /

+39.22 (+15.30%)

AAPL Apple
$133.12 /

-1.74 (-1.29%)

MSFT Microsoft
$258.22 /

-0.68 (-0.26%)

NNDM Nano Dimension
$7.14 /

+0.505 (+7.61%)

FUTU Futu Holdings
$136.22 /

-41.76 (-23.46%)

VRTX Vertex Pharmaceuticals
$219.96 /

+1.07 (+0.49%)

IBM IBM
$138.16 /

+5.07 (+3.81%)

JNJ Johnson & Johnson
$166.47 /

+3.66 (+2.25%)

TRV Travelers
$155.73 /

+1.28 (+0.83%)

PG Procter & Gamble
$137.76 /

+1.31 (+0.96%)

UAL United Airlines
$50.29 /

-4.72 (-8.58%)

KSU Kansas City Southern
$295.55 /

+39.22 (+15.30%)

CNI Canadian National
$110.17 /

-7.92 (-6.71%)

CP Canadian Pacific
$354.85 /

-10.33 (-2.83%)

AAPL Apple
$133.12 /

-1.74 (-1.29%)

MSFT Microsoft
$258.22 /

-0.68 (-0.26%)

NNDM Nano Dimension
$7.14 /

+0.505 (+7.61%)

SNDX Syndax
$13.42 /

-5.955 (-30.74%)

FUTU Futu Holdings
$136.22 /

-41.76 (-23.46%)

CRSP Crispr Therapeutics
$121.66 /

+6.5302 (+5.67%)

VRTX Vertex Pharmaceuticals
$219.96 /

+1.07 (+0.49%)

IBM IBM
$138.16 /

+5.07 (+3.81%)

JNJ Johnson & Johnson
$166.47 /

+3.66 (+2.25%)

TRV Travelers
$155.73 /

+1.28 (+0.83%)

PG Procter & Gamble
$137.76 /

+1.31 (+0.96%)

UAL United Airlines
$50.29 /

-4.72 (-8.58%)

KSU Kansas City Southern
$295.55 /

+39.22 (+15.30%)

AAPL Apple
$133.12 /

-1.74 (-1.29%)

MSFT Microsoft
$258.22 /

-0.68 (-0.26%)

NNDM Nano Dimension
$7.14 /

+0.505 (+7.61%)

FUTU Futu Holdings
$136.22 /

-41.76 (-23.46%)

CRSP Crispr Therapeutics
$121.66 /

+6.5302 (+5.67%)

VRTX Vertex Pharmaceuticals
$219.96 /

+1.07 (+0.49%)

Hot Stocks
Qiagen launches artus SARS-CoV-2 test kit » 16:07
04/20/21
04/20
16:07
04/20/21
16:07
QGEN

Qiagen

$52.15 /

-0.31 (-0.59%)

Qiagen announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QGEN Qiagen
$52.15 /

-0.31 (-0.59%)

QGEN Qiagen
$52.15 /

-0.31 (-0.59%)

02/19/21 Berenberg
Qiagen price target raised to EUR 56 from EUR 52 at Berenberg
02/09/21 William Blair
Quidel, Qiagen merger would not make sense, says William Blair
02/09/21 Wells Fargo
Qiagen shares should be sold on latest merger talk, says Wells Fargo
02/09/21 Citi
Merger with Qiagen would benefit Quidel, says Citi
QGEN Qiagen
$52.15 /

-0.31 (-0.59%)

QGEN Qiagen
$52.15 /

-0.31 (-0.59%)

QGEN Qiagen
$52.15 /

-0.31 (-0.59%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:24
04/20/21
04/20
12:24
04/20/21
12:24
IBM

IBM

$138.50 /

+5.41 (+4.06%)

, JNJ

Johnson & Johnson

$167.37 /

+4.56 (+2.80%)

, TRV

Travelers

$155.42 /

+0.97 (+0.63%)

, PG

Procter & Gamble

$138.30 /

+1.85 (+1.36%)

, UAL

United Airlines

$50.00 /

-5.01 (-9.11%)

, KSU

Kansas City Southern

$297.70 /

+41.37 (+16.14%)

, CNI

Canadian National

$111.09 /

-7 (-5.93%)

, NNDM

Nano Dimension

$7.10 /

+0.465 (+7.01%)

, AAP

Advance Auto Parts

$192.10 /

-0.32 (-0.17%)

, SNDX

Syndax

$13.67 /

-5.705 (-29.45%)

, FUTU

Futu Holdings

$145.27 /

-32.71 (-18.38%)

, CP

Canadian Pacific

$358.68 /

-6.5 (-1.78%)

The major averages are…

ShowHide Related Items >><<
UAL United Airlines
$50.00 /

-5.01 (-9.11%)

TRV Travelers
$155.42 /

+0.97 (+0.63%)

SNDX Syndax
$13.67 /

-5.705 (-29.45%)

PG Procter & Gamble
$138.30 /

+1.85 (+1.36%)

NNDM Nano Dimension
$7.10 /

+0.465 (+7.01%)

KSU Kansas City Southern
$297.70 /

+41.37 (+16.14%)

JNJ Johnson & Johnson
$167.37 /

+4.56 (+2.80%)

IBM IBM
$138.50 /

+5.41 (+4.06%)

FUTU Futu Holdings
$145.27 /

-32.71 (-18.38%)

CP Canadian Pacific
$358.68 /

-6.5 (-1.78%)

CNI Canadian National
$111.09 /

-7 (-5.93%)

AAP Advance Auto Parts
$192.10 /

-0.32 (-0.17%)

IBM IBM
$138.50 /

+5.41 (+4.06%)

07:32 Today Credit Suisse
IBM price target raised to $165 from $160 at Credit Suisse
07:09 Today Stifel
IBM price target raised to $151 from $147 at Stifel
06:50 Today Morgan Stanley
IBM price target raised to $152 at Morgan Stanley after Q1 results show progress
06:48 Today BMO Capital
IBM price target raised to $150 from $138 at BMO Capital
JNJ Johnson & Johnson
$167.37 /

+4.56 (+2.80%)

04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
TRV Travelers
$155.42 /

+0.97 (+0.63%)

04/01/21 Credit Suisse
Travelers price target raised to $153 from $142 at Credit Suisse
03/31/21 Citi
Travelers price target raised to $155 from $142 at Citi
03/24/21 Barclays
Travelers price target raised to $165 from $155 at Barclays
03/12/21 MKM Partners
Travelers price target raised to $185 from $175 at MKM Partners
PG Procter & Gamble
$138.30 /

+1.85 (+1.36%)

04/16/21 JPMorgan
Procter & Gamble price target lowered to $148 from $153 at JPMorgan
03/02/21 BofA
Procter & Gamble removed from the US 1 List at BofA
01/28/21 Stifel
Stifel downgrades Procter & Gamble to Hold on emerging headwinds
01/28/21 Stifel
Procter & Gamble downgraded to Hold from Buy at Stifel
UAL United Airlines
$50.00 /

-5.01 (-9.11%)

04/16/21
Fly Intel: Top five analyst upgrades
04/16/21 Argus
United Airlines upgraded to Buy on capacity and cost plans at Argus
04/16/21 Argus
United Airlines upgraded to Buy from Hold at Argus
04/15/21 Barclays
United Airlines price target raised to $62 from $44 at Barclays
KSU Kansas City Southern
$297.70 /

+41.37 (+16.14%)

04/19/21 Raymond James
Kansas City Southern downgraded to Outperform from Strong Buy at Raymond James
04/19/21 Raymond James
Kansas City Southern downgraded to Outperform from Strong Buy at Raymond James
04/15/21
Fly Intel: Top five analyst downgrades
04/15/21 Wells Fargo
Kansas City Southern downgraded to Equal Weight from Overweight at Wells Fargo
CNI Canadian National
$111.09 /

-7 (-5.93%)

04/09/21 Scotiabank
Canadian National price target raised to C$145 from C$140 at Scotiabank
03/31/21 National Bank
Canadian National price target raised to C$147 from C$137 at National Bank
03/26/21 CIBC
Canadian National price target raised to C$148 from C$142 at CIBC
03/26/21 Vertical Research
Canadian National reinstated with a Hold at Vertical Research
NNDM Nano Dimension
$7.10 /

+0.465 (+7.01%)

AAP Advance Auto Parts
$192.10 /

-0.32 (-0.17%)

04/19/21 Wells Fargo
Advance Auto Parts price target raised to $200 from $185 at Wells Fargo
04/16/21 Wedbush
Advance Auto Parts price target raised to $210 from $180 at Wedbush
03/26/21 Stephens
Advance Auto Parts price target raised to $180 from $175 at Stephens
03/17/21 Wells Fargo
Advance Auto Parts price target raised to $185 from $165 at Wells Fargo
SNDX Syndax
$13.67 /

-5.705 (-29.45%)

02/24/21 Piper Sandler
Kura Oncology price target lowered to $30 from $34 at Piper Sandler
02/18/21 B. Riley
Syndax initiated with Buy, $30 price target at B. Riley
02/17/21 B. Riley
Syndax initiated with a Buy at B. Riley Securities
01/29/21 Baird
Syndax assumed at Outperform at Baird
FUTU Futu Holdings
$145.27 /

-32.71 (-18.38%)

03/17/21 Citi
Futu Holdings price target lowered to $230.30 from $246.50 at Citi
02/26/21 Citi
Futu Holdings price target raised to $246.50 from $119.70 at Citi
02/22/21 86 Research
Futu Holdings downgraded to Hold from Buy at 86 Research
02/16/21 Morgan Stanley
Futu Holdings initiated with an Overweight at Morgan Stanley
CP Canadian Pacific
$358.68 /

-6.5 (-1.78%)

04/15/21
Fly Intel: Top five analyst upgrades
04/15/21 Barclays
Canadian Pacific upgraded to Overweight from Equal Weight at Barclays
04/09/21 Scotiabank
Canadian Pacific price target raised to C$516 from C$510 at Scotiabank
04/06/21 Susquehanna
Canadian Pacific-KSU deal should clear regulatory hurdles, says Susquehanna
UAL United Airlines
$50.00 /

-5.01 (-9.11%)

TRV Travelers
$155.42 /

+0.97 (+0.63%)

SNDX Syndax
$13.67 /

-5.705 (-29.45%)

PG Procter & Gamble
$138.30 /

+1.85 (+1.36%)

NNDM Nano Dimension
$7.10 /

+0.465 (+7.01%)

KSU Kansas City Southern
$297.70 /

+41.37 (+16.14%)

JNJ Johnson & Johnson
$167.37 /

+4.56 (+2.80%)

IBM IBM
$138.50 /

+5.41 (+4.06%)

CP Canadian Pacific
$358.68 /

-6.5 (-1.78%)

CNI Canadian National
$111.09 /

-7 (-5.93%)

AAP Advance Auto Parts
$192.10 /

-0.32 (-0.17%)

  • 21
    Apr
  • 09
    Dec
  • 19
    Aug
  • 30
    Apr
  • 22
    Apr
UAL United Airlines
$50.00 /

-5.01 (-9.11%)

TRV Travelers
$155.42 /

+0.97 (+0.63%)

PG Procter & Gamble
$138.30 /

+1.85 (+1.36%)

NNDM Nano Dimension
$7.10 /

+0.465 (+7.01%)

KSU Kansas City Southern
$297.70 /

+41.37 (+16.14%)

JNJ Johnson & Johnson
$167.37 /

+4.56 (+2.80%)

IBM IBM
$138.50 /

+5.41 (+4.06%)

FUTU Futu Holdings
$145.27 /

-32.71 (-18.38%)

UAL United Airlines
$50.00 /

-5.01 (-9.11%)

TRV Travelers
$155.42 /

+0.97 (+0.63%)

PG Procter & Gamble
$138.30 /

+1.85 (+1.36%)

NNDM Nano Dimension
$7.10 /

+0.465 (+7.01%)

KSU Kansas City Southern
$297.70 /

+41.37 (+16.14%)

JNJ Johnson & Johnson
$167.37 /

+4.56 (+2.80%)

IBM IBM
$138.50 /

+5.41 (+4.06%)

FUTU Futu Holdings
$145.27 /

-32.71 (-18.38%)

AAP Advance Auto Parts
$192.10 /

-0.32 (-0.17%)

UAL United Airlines
$50.00 /

-5.01 (-9.11%)

TRV Travelers
$155.42 /

+0.97 (+0.63%)

PG Procter & Gamble
$138.30 /

+1.85 (+1.36%)

NNDM Nano Dimension
$7.10 /

+0.465 (+7.01%)

KSU Kansas City Southern
$297.70 /

+41.37 (+16.14%)

JNJ Johnson & Johnson
$167.37 /

+4.56 (+2.80%)

IBM IBM
$138.50 /

+5.41 (+4.06%)

FUTU Futu Holdings
$145.27 /

-32.71 (-18.38%)

Recommendations
Amended pact may show Vertex confidence in Crisper program, says Chardan » 12:11
04/20/21
04/20
12:11
04/20/21
12:11
CRSP

Crispr Therapeutics

$120.80 /

+5.67 (+4.92%)

, VRTX

Vertex Pharmaceuticals

$220.44 /

+1.55 (+0.71%)

The amended CTX001…

The amended CTX001 collaboration agreement shifts the cost and profit sharing agreement between Crispr Therapeutics (CRSP) and Vertex Pharmaceuticals (VRTX) on the autologous ex vivo gene-edited cell therapy program for hemoglobinopathies from 50/50 to 60/40, with Vertex taking the lead, Chardan analyst Geulah Livshits tells investors in a research note. The move may signal Vertex's confidence in the program from a competitive standpoint and is a "reasonable strategy to maximize market capture upon potential launch," says the analyst. Livshits keeps a Buy rating on Crispr Therapeutics with a $175 price target.

ShowHide Related Items >><<
VRTX Vertex Pharmaceuticals
$220.44 /

+1.55 (+0.71%)

CRSP Crispr Therapeutics
$120.80 /

+5.67 (+4.92%)

CRSP Crispr Therapeutics
$120.80 /

+5.67 (+4.92%)

03/17/21 Guggenheim
Editas Medicine assumed with a Neutral at Guggenheim
03/04/21 JMP Securities
Crispr Therapeutics initiated with an Outperform at JMP Securities
03/01/21 Barclays
Crispr Therapeutics price target raised to $140 from $113 at Barclays
02/17/21 Goldman Sachs
Crispr Therapeutics price target lowered to $189 from $193 at Goldman Sachs
VRTX Vertex Pharmaceuticals
$220.44 /

+1.55 (+0.71%)

03/25/21 Citi
Citi likes share setup for Vertex Pharmaceuticals, adds to Focus List
02/23/21 Baird
Baird upgrades Vertex Pharmaceuticals, shares attractive ahead of readouts
02/23/21 Baird
Vertex Pharmaceuticals upgraded to Outperform from Neutral at Baird
02/02/21 Credit Suisse
Vertex Pharmaceuticals price target lowered to $280 from $285 at Credit Suisse
VRTX Vertex Pharmaceuticals
$220.44 /

+1.55 (+0.71%)

CRSP Crispr Therapeutics
$120.80 /

+5.67 (+4.92%)

  • 01
    Jul
VRTX Vertex Pharmaceuticals
$220.44 /

+1.55 (+0.71%)

VRTX Vertex Pharmaceuticals
$220.44 /

+1.55 (+0.71%)

CRSP Crispr Therapeutics
$120.80 /

+5.67 (+4.92%)

VRTX Vertex Pharmaceuticals
$220.44 /

+1.55 (+0.71%)

CRSP Crispr Therapeutics
$120.80 /

+5.67 (+4.92%)

Hot Stocks
Philips reports five-year meta-analysis of Stellarex drug-coated balloon » 11:27
04/20/21
04/20
11:27
04/20/21
11:27
PHG

Philips

$59.85 /

-0.84 (-1.38%)

Royal Philips announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PHG Philips
$59.85 /

-0.84 (-1.38%)

PHG Philips
$59.85 /

-0.84 (-1.38%)

03/23/21 Barclays
Philips price target raised to EUR 55 from EUR 54 at Barclays
03/18/21 JPMorgan
Philips price target raised to EUR 50.70 from EUR 44.90 at JPMorgan
03/18/21 JPMorgan
Philips upgraded to Overweight from Neutral at JPMorgan
01/26/21 Credit Suisse
Philips price target raised to EUR 45 from EUR 41 at Credit Suisse
PHG Philips
$59.85 /

-0.84 (-1.38%)

PHG Philips
$59.85 /

-0.84 (-1.38%)

PHG Philips
$59.85 /

-0.84 (-1.38%)

Hot Stocks
EMA recommends clot warning for J&J vaccine, says benefit still positive » 10:15
04/20/21
04/20
10:15
04/20/21
10:15
JNJ

Johnson & Johnson

$164.54 /

+1.73 (+1.06%)

, AZN

AstraZeneca

$52.12 /

+0.465 (+0.90%)

The European Medicines…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$164.54 /

+1.73 (+1.06%)

AZN AstraZeneca
$52.12 /

+0.465 (+0.90%)

JNJ Johnson & Johnson
$164.54 /

+1.73 (+1.06%)

04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
AZN AstraZeneca
$52.12 /

+0.465 (+0.90%)

04/12/21
Fly Intel: Top five analyst downgrades
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
04/12/21 Argus
AstraZeneca downgraded to Hold from Buy at Argus
JNJ Johnson & Johnson
$164.54 /

+1.73 (+1.06%)

AZN AstraZeneca
$52.12 /

+0.465 (+0.90%)

JNJ Johnson & Johnson
$164.54 /

+1.73 (+1.06%)

AZN AstraZeneca
$52.12 /

+0.465 (+0.90%)

JNJ Johnson & Johnson
$164.54 /

+1.73 (+1.06%)

AZN AstraZeneca
$52.12 /

+0.465 (+0.90%)

JNJ Johnson & Johnson
$164.54 /

+1.73 (+1.06%)

AZN AstraZeneca
$52.12 /

+0.465 (+0.90%)

Downgrade
PPD downgraded to Hold from Buy at Jefferies » 08:30
04/20/21
04/20
08:30
04/20/21
08:30
PPD

PPD

$46.20 /

-0.1 (-0.22%)

Jefferies analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PPD PPD
$46.20 /

-0.1 (-0.22%)

PPD PPD
$46.20 /

-0.1 (-0.22%)

04/19/21
Fly Intel: Top five analyst downgrades
04/19/21 Citi
PPD downgraded to Neutral from Buy at Citi
04/19/21 Mizuho
PPD downgraded to Neutral from Buy at Mizuho
04/19/21 Credit Suisse
PPD downgraded to Neutral from Outperform at Credit Suisse
PPD PPD
$46.20 /

-0.1 (-0.22%)

  • 17
    Sep
PPD PPD
$46.20 /

-0.1 (-0.22%)

PPD PPD
$46.20 /

-0.1 (-0.22%)

Hot Stocks
Coherus announces closing of $50M sale of common stock to Junshi » 08:19
04/20/21
04/20
08:19
04/20/21
08:19
CHRS

Coherus Biosciences

$14.15 /

-0.255 (-1.77%)

Coherus BioSciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHRS Coherus Biosciences
$14.15 /

-0.255 (-1.77%)

CHRS Coherus Biosciences
$14.15 /

-0.255 (-1.77%)

02/25/21 Citi
Coherus Biosciences price target lowered to $27 from $30 at Citi
02/25/21 H.C. Wainwright
Coherus Biosciences price target lowered to $29 from $33 at H.C. Wainwright
11/19/20 Mizuho
Coherus Biosciences price target lowered to $30 from $35 at Mizuho
08/21/20 Mizuho
Express Scripts exclusion does not impact Coherus, says Mizuho
CHRS Coherus Biosciences
$14.15 /

-0.255 (-1.77%)

Conference/Events
Syndax to host conference call » 08:12
04/20/21
04/20
08:12
04/20/21
08:12
SNDX

Syndax

$19.38 /

-1.005 (-4.93%)

Conference call to…

Conference call to discuss Positive Interim Data Demonstrating Robust Clinical Activity in Phase 1 Portion of the AUGMENT-101 Trial of SNDX-5613 in Patients with Genetically-Defined Acute Leukemias will be held on April 20 at 8 am.Webcast Link

ShowHide Related Items >><<
SNDX Syndax
$19.38 /

-1.005 (-4.93%)

SNDX Syndax
$19.38 /

-1.005 (-4.93%)

02/24/21 Piper Sandler
Kura Oncology price target lowered to $30 from $34 at Piper Sandler
02/18/21 B. Riley
Syndax initiated with Buy, $30 price target at B. Riley
02/17/21 B. Riley
Syndax initiated with a Buy at B. Riley Securities
01/29/21 Baird
Syndax assumed at Outperform at Baird
SNDX Syndax
$19.38 /

-1.005 (-4.93%)

  • 09
    Dec
  • 30
    Apr
Hot Stocks
Spine BioPharma announces $3M investment by Pacira Biosciences » 07:33
04/20/21
04/20
07:33
04/20/21
07:33
PCRX

Pacira

$63.57 /

+0.54 (+0.86%)

Spine BioPharma announced…

Spine BioPharma announced a $3M investment by Pacira Biosciences in the form of a convertible note. The investment will support the further development of Remedisc, a therapeutic for the treatment of degenerative disc disease. Pacira will make an additional $7M investment predicated upon achieving certain prespecified milestones. Marc Viscogliosi, CEO of Spine BioPharma, stated, "We are delighted to welcome two investment partners that bring significant biopharma expertise, relationships, and scale to our ambitious mission of changing the lives of millions of patients suffering from chronic low back pain. Remedisc represents a unique, best-in-class, first-in-class therapeutic that can provide a non-opiate, non-surgical treatment option to these patients." Spine FDA seeking approval of a Phase 2/3 multicenter, randomized controlled study of Remedisc later this year.

ShowHide Related Items >><<
PCRX Pacira
$63.57 /

+0.54 (+0.86%)

PCRX Pacira
$63.57 /

+0.54 (+0.86%)

04/09/21 Berenberg
Pacira initiated with a Buy at Berenberg
04/06/21 RBC Capital
Pacira transferred with an Outperform at RBC Capital
03/01/21 H.C. Wainwright
Pacira price target raised to $86 from $70 at H.C. Wainwright
02/26/21 Barclays
Pacira price target raised to $94 from $79 at Barclays
PCRX Pacira
$63.57 /

+0.54 (+0.86%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.